Shire Enters Supply Agreement
Shire's United States subsidiary enters supply agreement for Adderall XR.
Shire reported that its subsidiary Shire US has entered into an agreement to supply an authorized generic version of its product Adderall XR. Under the agreement, Sandoz will market an authorized generic version of Adderall XR beginning July 1, 2016. From the Dec. 1, 2013 effective date of the agreement through the end of the agreement’s five-year term, Sandoz has agreed to exclusively sell the authorized generic version of Adderall XR supplied by Shire.
Shire will manufacture and supply Sandoz with all dosage strengths of the authorized generic product. Sandoz will distribute the product in the US. Shire will receive a royalty from Sandoz’s sales of the product.
Source: Shire
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
